PCM
COLL icon

Penn Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Penn Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-244,516
Closed -$9.53M – 154
2024
Q1 		$9.53M Sell
244,516
-71,258
-23% -$2.49M 0.85% 62
2023
Q4 		$9.76M Buy
+315,774
New +$7.91M 0.89% 57
2023
Q3 		– Sell
-105,359
Closed -$2.26M – 152
2023
Q2 		$2.26M Buy
+105,359
New +$2.39M 0.22% 103

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Penn Capital Management's COLL Position: Q2 2024 in Review

Penn Capital Management sold out of Collegium Pharmaceutical (COLL) in Q2 2024, closing a stake of 244,516 shares — an estimated $9.53M sold.

Penn Capital Management first reported a position in COLL in Q2 2023 and held it in 3 quarters. The position peaked at $9.76M in Q4 2023. 229 funds tracked by Wall St. Rank hold COLL as of Q2 2024.

  • Penn Capital Management reported no remaining Collegium Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Penn Capital Management sold 244,516 Collegium Pharmaceutical shares in Q2 2024, an estimated $9.53M.
  • Penn Capital Management first reported a position in Collegium Pharmaceutical in Q2 2023 and held it in 3 quarters.
  • Penn Capital Management's Collegium Pharmaceutical position peaked at $9.76M in Q4 2023.
  • 229 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2024.

Based on Penn Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.